Indian equities may see a short-term recovery as valuations become more reasonable and earnings expectations stabilise, according to Sanjay Mookim, Head of India Equity...
Speaking at JPMorgan’s 10th Annual India Conference, Bansi Desai, VP - India Healthcare & Pharma Research at JPMorgan, outlined how Indian pharmaceutical companies generate...
India has become a major focus for JPMorgan’s investment banking business in Asia Pacific, according to Paul Uren, Head of Investment Banking for the...